Logo image of SPEC

SPECTAIRE HOLDINGS INC (SPEC) Stock Fundamental Analysis

NASDAQ:SPEC - Nasdaq - US84753T1097 - Common Stock - Currency: USD

0.1561  -0.13 (-45.72%)

After market: 0.16 +0 (+2.5%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SPEC. SPEC was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of SPEC have multiple concerns. SPEC is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SPEC had positive earnings in the past year.
SPEC had a negative operating cash flow in the past year.
SPEC Yearly Net Income VS EBIT VS OCF VS FCFSPEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 5M -5M -10M -15M

1.2 Ratios

SPEC has a Return On Assets of 2345.80%. This is amongst the best in the industry. SPEC outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 2345.8%
ROE N/A
ROIC N/A
ROA(3y)204.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPEC Yearly ROA, ROE, ROICSPEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 200 400 600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SPEC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPEC Yearly Profit, Operating, Gross MarginsSPEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for SPEC has been increased compared to 1 year ago.
Compared to 1 year ago, SPEC has a worse debt to assets ratio.
SPEC Yearly Shares OutstandingSPEC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
SPEC Yearly Total Debt VS Total AssetsSPEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

SPEC has an Altman-Z score of -127.25. This is a bad value and indicates that SPEC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -127.25, SPEC is doing worse than 98.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -127.25
ROIC/WACCN/A
WACCN/A
SPEC Yearly LT Debt VS Equity VS FCFSPEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

SPEC has a Current Ratio of 0.02. This is a bad value and indicates that SPEC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SPEC (0.02) is worse than 98.44% of its industry peers.
SPEC has a Quick Ratio of 0.02. This is a bad value and indicates that SPEC is not financially healthy enough and could expect problems in meeting its short term obligations.
SPEC has a Quick ratio of 0.02. This is amonst the worse of the industry: SPEC underperforms 99.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
SPEC Yearly Current Assets VS Current LiabilitesSPEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 432.98% over the past year.
EPS 1Y (TTM)432.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SPEC will show a very strong growth in Earnings Per Share. The EPS will grow by 46.73% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y92.14%
EPS Next 2Y46.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPEC Yearly Revenue VS EstimatesSPEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 10M 20M 30M 40M
SPEC Yearly EPS VS EstimatesSPEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 -0.5 -1 -1.5 -2

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

SPEC is valuated cheaply with a Price/Earnings ratio of 0.12.
SPEC's Price/Earnings ratio is rather cheap when compared to the industry. SPEC is cheaper than 100.00% of the companies in the same industry.
SPEC is valuated cheaply when we compare the Price/Earnings ratio to 26.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 0.44, the valuation of SPEC can be described as very cheap.
Based on the Price/Forward Earnings ratio, SPEC is valued cheaply inside the industry as 99.22% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SPEC to the average of the S&P500 Index (22.19), we can say SPEC is valued rather cheaply.
Industry RankSector Rank
PE 0.12
Fwd PE 0.44
SPEC Price Earnings VS Forward Price EarningsSPEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPEC Per share dataSPEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SPEC's earnings are expected to grow with 46.73% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y46.73%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SPEC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPECTAIRE HOLDINGS INC

NASDAQ:SPEC (8/6/2024, 8:00:03 PM)

After market: 0.16 +0 (+2.5%)

0.1561

-0.13 (-45.72%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.5%
Inst Owner Change-31.85%
Ins Owners53.96%
Ins Owner Change0%
Market Cap2.90M
Analysts43.33
Price Target1.84 (1078.73%)
Short Float %0.39%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.12
Fwd PE 0.44
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.33
EY852.02%
EPS(NY)0.36
Fwd EY228.7%
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0
BVpS-1.53
TBVpS-1.53
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2345.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)204.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -127.25
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)432.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.61%
EPS Next Y92.14%
EPS Next 2Y46.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-138.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1045.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1037.14%
OCF growth 3YN/A
OCF growth 5YN/A